Boeing Rises as CEO Touts 737 Output, New Jet Approvals Nearing

Boeing said it has completed an FAA capstone review to lift 737 Max production to 47 jets per month, a key step toward improved profitability and cash generation. The company is in final flight testing for the 737 Max 7 and 10 as well as the 777X, while 787 deliveries are still constrained by seat certification and GE Aerospace engine supply bottlenecks. Management also flagged a favorable defense spending outlook.

Analysis

The market is likely to underappreciate how much of Boeing’s equity story is now a throughput story rather than an order story. If production can actually step up without a quality reset, the operating leverage is enormous: every incremental monthly build rate improves cash conversion, but the bigger second-order effect is on supplier confidence and working-capital drag across the narrowbody chain. That said, the path to higher cash is less about headline certification milestones and more about whether the factory can hold the new rate for multiple quarters without triggering rework, which is where this name has repeatedly failed.

The most important bearish nuance is that bottlenecks shifting downstream do not disappear; they migrate. If cabin certification and engine supply remain constrained, Boeing’s delivery cadence can still lag production, meaning inventory builds and customer compensation can delay the inflection in free cash flow by 1-2 quarters even if unit output rises. That creates a setup where the stock can rerate on optimism before the numbers catch up, but it also means any manufacturing hiccup would be punished immediately because expectations are already moving higher.

For GE, the negative read-through is subtle but real: any constraint at the engine supplier is now a bargaining chip, not just an operational issue. If Boeing is pushing rates higher, GE Aerospace gains pricing leverage on the aftermarket and spares side, but near-term delivery timing can also create lumpiness in engine shipments and working capital. The defense angle is more durable and multi-year, but it is a slower monetization channel; the real near-term driver remains commercial execution, not budget headlines.

Consensus likely misses that this is a late-cycle quality-of-execution trade, not a simple reopening story. The upside case is asymmetric if Boeing sustains rate gains for 2-3 quarters, but the downside is equally sharp because the market has little patience for another false dawn. In that sense, the better expression may be to own the supplier with pricing power and shorter cycle visibility, while treating Boeing itself as a tactical trade until delivery data prove the ramp is real.

Key Decisions for Investors

• Long GE / short BA for the next 1-3 months: if Boeing’s ramp is real, GE benefits from engine demand and aftermarket pricing; if Boeing stumbles, GE’s downside is cushioned by services, while BA re-rates lower on execution risk. Target a 1.5-2.0x upside/downside asymmetry.
• Initiate a tactical BA long only on pullbacks, sized small, with a 6-8 week horizon: the stock can squeeze on production optimism, but use a tight risk limit because any delivery or quality setback likely compresses multiple quickly.
• Buy GE call spreads 3-6 months out: this captures upside from sustained narrowbody output and defense exposure while limiting premium outlay if Boeing’s production ramp proves noisy.
• Avoid chasing BA strength into the event cycle; wait for the next monthly delivery/production data point before adding risk. The trade works only if evidence confirms the ramp, not on narrative alone.
• Relative-value long industrial aerospace suppliers with cleaner execution versus BA: if available in the book, pair BA against a diversified aerospace supplier basket to isolate execution risk from sector beta.